Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia.The modernization will enable the company to expand ...

"Haleon's choice to expand its research capabilities and upgrade its Richmond facility strengthens the Commonwealth's pharmaceutical sector and highlights why Virginia is America’s Top State for ...

Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state government and Virginia ...

Haleon HLN-0.75 % decrease; red down pointing triangle posted a higher pretax profit for 2024 despite lower revenue, and said it expected further organic revenue and profit growth this year.

Additionally, a five-year internship program will be launched in partnership with Virginia Commonwealth University (VCU) with ...

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond. The Latest; ... With roots in Central Virginia dating back to the 1960s, ...

Haleon, an international manufacturer of medicine, vitamins and toothpaste, will upgrade its lab in Richmond’s North Side at a cost of $54 million, the company announced Monday. Based in England ...

Check out our HLN stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024.

Haleon reported lower adjusted profits for 2023 despite better-than-expected sales and positive volume, price and organic growth, and confirmed its revenue target for this year.

The expansion was announced in a press conference held on Monday, Jan. 27, detailing how Haleon, a global health company, plans to invest $54.2 million for upgrades to the Richmond facility ...